We incorporate approved tumor killing molecules with high accretion to the bone mineral i.e., Hydroxyapatite (HA). In addition, a systemic loading of a specific drug will seek, bind, and exert a local biological effect. This increases the efficacy of targeted drug delivery without causing side-effects in other tissues.